In this episode, physician-scientist Alejandro Chavez (Columbia University) discusses the development and features of the CRISPR activation platform, which is commercially available from Horizon. Chavez also offers his views on the breadth of applications of CRISPRa/CRISPRi technology for genetics research.

CRISPR Functional Genomics Miniseries, Episode #1: Alejandro Chavez

Mary Ann Liebert, Inc. is a leading company in the Scientific, Technical, and Medical knowledge and information industry. We are known for authoritative international publications in cutting-edge basic and translational biomedical research, with expanding scope in engineering, business, environment, and legal publications. These publications play an active and important role in advancing critical research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policy makers, and educators.

Share CRISPR Functional Genomics Miniseries, Episode #1: Alejandro Chavez

Sign up to save your podcasts

CRISPR Functional Genomics Miniseries, Episode #1: Alejandro Chavez

CRISPR Functional Genomics Miniseries, Episode #1: Alejandro Chavez